Is Scientific Medical Literature Related to Endometriosis Treatment Evidence-Based? A Systematic Review on Methodological Quality of Randomized Clinical Trials
This systematic review found that none of the 38 evaluated randomized controlled trials on endometriosis therapy met all methodological criteria for reporting and providing sufficient detail for study reproduction.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (93)
- A dose‐ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosis via openalex
- A randomized study comparing the side effects and hormonal status of triptorelin and leuprorelin following conservative laparoscopic surgery for ovarian endometriosis in Chinese women via openalex
- Assessing research gaps and unmet needs in endometriosis via openalex
- Association Between Endometriosis and Hypercholesterolemia or Hypertension via openalex
- Characteristics of Women with Endometriosis from the USA and Puerto Rico via openalex
- Combined laparoscopic surgery and pentoxifylline therapy for treatment of endometriosis-associated infertility: a preliminary trial via openalex
- Comparison study on effectiveness of pentoxifyllin with LD to prevent recurrent endometriosis. via openalex
- Detailed analysis of a randomized, multicenter, comparative trial of dienogest versus leuprolide acetate in endometriosis via openalex
- Dienogest for Treatment of Endometriosis in Chinese Women: A Placebo-Controlled, Randomized, Double-Blind Phase 3 Study via openalex
- Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study via openalex
- Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial via openalex
- Disparity in endometriosis diagnoses between racial/ethnic groups via openalex
- East and South East Asian Ethnicity and Moderate-to-Severe Endometriosis via openalex
- Effectiveness of the association micronized N-Palmitoylethanolamine (PEA)–transpolydatin in the treatment of chronic pelvic pain related to endometriosis after laparoscopic assessment: a pilot study via openalex
- Efficacy and Safety Investigation of Kuntai Capsule for the Add-back Therapy of Gonadotropin Releasing Hormone Agonist Administration to Endometriosis Patients via openalex
- Efficacy and Safety of Remifemin on Peri-Menopausal Symptoms Induced by Post-Operative GnRH-a Therapy for Endometriosis: A Randomized Study versus Tibolone via openalex
- Efficacy of levonorgestrel releasing intrauterine system as a postoperative maintenance therapy of endometriosis: A meta-analysis via openalex
- Efficacy of melatonin in the treatment of endometriosis: A phase II, randomized, double-blind, placebo-controlled trial via openalex
- Elagolix, an Oral GnRH Antagonist, Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis: Effects on Bone Mineral Density via openalex
- Elagolix Treatment for Endometriosis-Associated Pain: Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study via openalex
- Endometriosis: advances and controversies in classification, pathogenesis, diagnosis, and treatment via openalex
- Endometriosis and Risk of Coronary Heart Disease via openalex
- Endometriosis still a challenge. via openalex
- Ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen for the management of endometriosis-associated pelvic pain: a randomized controlled trial via openalex
- Gonadotrophin‐releasing hormone analogue or dienogest plus estradiol valerate to prevent pain recurrence after laparoscopic surgery for endometriosis: a multi‐center randomized trial via openalex
- Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis via openalex
- Influence of race/ethnicity on prevalence and presentation of endometriosis: a systematic review and meta‐analysis via openalex
- Initiation of GnRH agonist treatment on 3-5 days postoperatively in endometriosis patients: a randomized controlled trial via openalex
- Lactobacillus gasseri OLL2809 is effective especially on the menstrual pain and dysmenorrhea in endometriosis patients: randomized, double-blind, placebo-controlled study via openalex
- Letrozole and norethisterone acetate versus letrozole and triptorelin in the treatment of endometriosis related pain symptoms: a randomized controlled trial via openalex
- Levonorgestrel‐releasing intrauterine system (Mirena <sup>®</sup> ) and Depot medroxyprogesterone acetate (Depoprovera) as long‐term maintenance therapy for patients with moderate and severe endometriosis: A randomised controlled trial via openalex
- Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial via openalex
- Micronized palmitoylethanolamide/trans-polydatin treatment of endometriosis-related pain: a meta-analysis. via openalex
- Mifepristone 2.5, 5, 10mg versus placebo in the treatment of endometriosis via openalex
- Oral continuous combined 0.5 mg estradiol valerate and 5 mg dydrogesterone as daily add-back therapy during post-operative GnRH agonist treatment for endometriosis in Chinese women. via openalex
- Pathogenesis of endometriosis: Interaction between Endocrine and inflammatory pathways via openalex
- Pentoxifylline After Conservative Surgery for Endometriosis: A Randomized, Controlled Trial via openalex
- Potentized estrogen in homeopathic treatment of endometriosis-associated pelvic pain: A 24-week, randomized, double-blind, placebo-controlled study via openalex
- The association between endometriosis and autoimmune diseases: a systematic review and meta-analysis via openalex
- The Use of Resveratrol as an Adjuvant Treatment of Pain in Endometriosis: A Randomized Clinical Trial via openalex
- Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist via openalex
- Treatment of endometriosis in different ethnic populations: a meta-analysis of two clinical trials via openalex
- W2131027406 via openalex
- W2139339819 via openalex
- W2144981148 via openalex
- W2049015634 via openalex
- W2148368274 via openalex
- W2151934245 via openalex
- W2153127029 via openalex
- W2037198884 via openalex
- W2161095279 via openalex
- W2161191869 via openalex
- W2016300030 via openalex
- W2165352868 via openalex
- W2001163355 via openalex
- W2171466862 via openalex
- W2197415496 via openalex
- W2261075010 via openalex
- W2318707379 via openalex
- W1994742944 via openalex
- W2331384579 via openalex
- W2468038336 via openalex
- W2481029616 via openalex
- W2616141209 via openalex
- W2736834206 via openalex
- W1982375973 via openalex
- W2753009994 via openalex
- W1978085719 via openalex
- W2809266094 via openalex
- W1975317736 via openalex
- W1968350578 via openalex
- W1966091296 via openalex
- W1962375501 via openalex
- W1580924603 via openalex
- W1247968195 via openalex
- W3124789634 via openalex
- W4236805817 via openalex
- W6603083840 via openalex
- W6628947381 via openalex
- W6635732373 via openalex
- W6675920276 via openalex
- W6687566510 via openalex
- W6740698509 via openalex
- W2095312096 via openalex
- W6744025391 via openalex
- W2096910661 via openalex
- W2096980318 via openalex
- W2049397178 via openalex
- W2049321668 via openalex
- W2101386379 via openalex
- W2101417341 via openalex
- W2107529266 via openalex
- W2108696783 via openalex
Cited by (4)
- Mobile applications for endometriosis management functionalities: Analysis and potential 2023
- A review of phase II and III drugs for the treatment and management of endometriosis 2023
- Is it the Ideal Time to Start Prescribing Cannabis Derivatives to Treat Endometriosis-associated Pain? 2022
- Stepwise Approach to the Management of Endometriosis-Related Dysmenorrhea 2021
Source provenance
- europepmc
- last seen: 2026-06-13T06:22:48.782012+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:22:41.077124+00:00